Abeona Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.About ABEO
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).
ABEO Key Statistics
Stock Snapshot
The current Abeona Therapeutics(ABEO) stock price is $5.46, with a market capitalization of 311.48M. The stock trades at a price-to-earnings (P/E) ratio of 5.83.
As of 2026-06-06, Abeona Therapeutics(ABEO) stock has fluctuated between $5.42 and $5.84. The current price stands at $5.46, placing the stock +0.8% above today's low and -6.5% off the high.
The Abeona Therapeutics(ABEO)'s current trading volume is 875.78K, compared to an average daily volume of 774.27K.
In the last year, Abeona Therapeutics(ABEO) shares hit a 52-week high of $7.54 and a 52-week low of $4.00.
In the last year, Abeona Therapeutics(ABEO) shares hit a 52-week high of $7.54 and a 52-week low of $4.00.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.